HealthTree News

February 21, 2025

Jenny Ahlstrom shares her blood cancer journey and the creation of HealthTree Foundation on The Pulse podcast.

February 18, 2025

If CAR T-cell therapy does not work, how effective are bispecific antibodies for people with large B-cell lymphoma? Learn answers from a recent study.

February 13, 2025

Read the clinical trial updates on a promising treatment combination that uses epcoritamab, rituximab, and lenalidomide. 

February 13, 2025

FDA approves a new combo therapy for relapsed/refractory large B-cell lymphoma, offering support for patients ineligible for transplant or CAR T-cell therapy.

February 11, 2025

Explore glofitamab, a promising treatment for relapsed/refractory follicular lymphoma, offering fewer side effects and longer remission.

February 10, 2025

Explore side effects of bispecific antibodies for myeloma and B-cell lymphoma treatment, comparing brands on CRS, ICANS, and IEC-HS severity.

February 05, 2025

Researchers explore if BHB from a keto diet can boost CAR T-cell therapy for LBCL patients. Clinical trials aim to assess its effectiveness.

February 04, 2025

Discover how CAR T-cell therapy (tisagenlecleucel) performs in real-world follicular lymphoma patients with promising outcomes and safety.

February 04, 2025

HealthTree recognizes researchers with Innovation and Real-World Data Awards at ASH 2024, celebrating advancements in blood cancer research and patient care.

February 03, 2025

New real-world data shows improved survival outcomes for Black DLBCL patients, highlighting the impact of R-CHOP and better insurance coverage.